"We will apply for FDA Emergency Use Authorization so our analyzer can be used to detect coronavirus and other respiratory pathogens for clinical use."
LexaGene announced on Twitter Mar 4.
This is very good news. The FDA should award this with no hesitation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.